NASDAQ

Keros Therapeutics, Inc. (KROS)

♥ 537 Thanks from members

Live price chart, market sentiment, and community perspectives for Keros Therapeutics, Inc. (NASDAQ: KROS).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Keros Therapeutics TeamLeadership: Jasbir Seehra (President and CEO)Holder: RA Capital ManagementHolder: Fidelity Management and ResearchHolder: Vivo CapitalKER-050KER-012Transforming growth factor-beta therapeutics#KROS stock#Keros Therapeutics#TGF-beta inhibitors#biopharma clinical stage#rare disease treatment